Skip to main content

Client News

invIOs presents exciting preclinical data showing that immune-activating small molecule INV501 induces strong cytotoxic activity against solid tumors

19th June 2023

Abivax receives “Capital Market Transaction of the Year Award” at the European Mediscience Awards 2023

15th June 2023

Digital health start-up Capreolos GmbH launches Ready4OP app to support patients before major surgical procedures

15th June 2023

Medigene AG: Medigene to Host Virtual R&D Event on TCR-T Therapies for Solid Tumors

13th June 2023

ITM Opens World’s Largest Lutetium-177 Production Facility for Targeted Radionuclide Therapies Against Cancer

13th June 2023

Biotalys announces closing of private placement

12th June 2023

Abivax stock included in MSCI indexes

8th June 2023

Biotalys Strengthens Relationship with Investors via Private Placement of New Shares for €7 million

7th June 2023

Abivax releases the results of its June 5, 2023 ordinary and extraordinary general meeting

6th June 2023

Carbios aims to be a leader in growing r-PET market with an ambition to capture 8 to 12% share by 2035 through licensing model

6th June 2023

Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expression

5th June 2023

Element Materials creates a new Lab Solutions division within Life Sciences, providing advanced equipment for laboratories

5th June 2023

Carbios and Indorama Ventures reaffirm partnership to build first-of-a-kind PET biorecycling plant in France

1st June 2023

Medigene AG: Medigene Announces Pipeline Expansion into Neoantigens with Programs Targeting Multiple KRAS Mutations and HLAs

1st June 2023

Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies for treatment of ophthalmic disease

1st June 2023

Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model compared to 8.2 % in institutional database with asunercept plus standard of care in newly diagnosed glioblastoma multiforme patients

1st June 2023

Carbios will receive grants totaling €54 million from French State via France 2030 and Grand-Est Region[1] to finance construction of world’s first PET biorecycling plant and accelerate R&D activities

31st May 2023

Mainz Biomed Expands Commercial Footprint into Poland

31st May 2023

Biotalys Continues to Demonstrate Strength of First Biocontrol in Latest Global Field Trials

31st May 2023

Destiny Pharma: Board Changes Dr Debra Barker Appointed Interim CEO

25th May 2023

ONWARD: Brain Computer Interface (BCI) Enables Thought-Controlled Walking after Spinal Cord Injury

25th May 2023

Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöller-Kipper

24th May 2023

Medigene AG: Medigene Expands Patent Portfolio for its End-to-End Platform

22nd May 2023

MIG Capital: MIG Capital strengthens its investment team with four new professionals

17th May 2023

LEON appoints Dr. Setu Kasera as Chief Scientific Officer

16th May 2023

Mainz Biomed Announces First Quarter 2023 Financial Results and Provides Corporate Update

16th May 2023

Carbios recognized as a flagship start-up in French green innovation at the Choose France Summit

16th May 2023

ONWARD Reports Q1 Business Update and Year-To-Date Highlights

16th May 2023

ONWARD Announces First-in-Human Use of ARC-IM™ Lead to Restore Movement and Function after Spinal Cord Injury

15th May 2023

Rentschler Biopharma supports the Laupheim Planetarium with a donation of 25,000 Euros

15th May 2023

Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases

15th May 2023

Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)

15th May 2023

InflaRx Reports First Quarter 2023 Financial and Operating Results and Provides Business Update

11th May 2023

VPM contributes to the successful licensure of the novel malaria vaccine R21/Matrix-MTM for first use in Ghana

10th May 2023

Andera Partners appoints Stefan Keitel Senior Advisor DACH region further strengthening its presence in the German, Austrian and Swiss private equity markets

10th May 2023